Monthly Archives

February 2014

CluePoints Strengthens and Expands Global Team in Growing Risk-Based Monitoring Market

By | News | No Comments


Company announces new board and business development appointments

25th February 2014

Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) solutions for clinical trials, has announced three new appointments to its global team. John Colby and Elizabeth Polvent join the company’s U.S business development team, fulfilling a key element in its strategy for growth, while CluePoints also welcomes Jean Stéphenne, President of the Board of Directors of GlaxoSmithKline Biologicals, as a member of its board.…